Literature DB >> 11726283

Characterization of phagosomal subpopulations along endocytic routes in osteoclasts and macrophages.

E Sakai1, H Miyamoto, K Okamoto, Y Kato, K Yamamoto, H Sakai.   

Abstract

Modifications occurring during the transformation of phagosomes into mature phagolysosomes were investigated in osteoclast-like cells (OCLs) and macrophages using latex beads as markers for the isolation of phagosomal compartments (LBC) at different time points after phagocytosis. In OCLs, newly formed LBC acquired cathepsin K, tartarate-resistant phosphatase (TRAP), lysosome-associated membrane protein-1 (Lamp-1), and cathepsin D, and rapidly lost annexin II in a time-dependent manner. The levels of Rab7 and c-Src in OCLs initially increased and then gradually decreased during the transformation from early to late endosomal LBC or phagolysosomes. Receptor activator of NF-kappaB (RANKL) significantly increased the LBC levels of cathepsin K, TRAP, and c-Src, whereas calcitonin decreased the LBC levels of cathepsin K, TRAP, and Rab7, indicating that the transformation of early to late endosomal elements and lysosomes in OCLs is also regulated by osteoclastogenesis regulatory factors. On the other hand, changes in the LBC levels of Lamp-1, cathepsin D, and annexin II in macrophages were comparable to those in OCLs. However, contrary to osteoclastic LBC, Rab7 levels of macrophage LBC decreased in a time-dependent manner. Macrophage LBC were devoid of cathepsin K, TRAP, and c-Src in all transformation stages. These observations suggest that OCLs and macrophages have different phagosome maturation mechanisms that involve the specific and regulated acquisition of markers from endocytic organelles. The results also demonstrate that the use of LBC is a useful system in which to identify and characterize molecules involved in these different endocytic pathways.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11726283     DOI: 10.1093/oxfordjournals.jbchem.a003054

Source DB:  PubMed          Journal:  J Biochem        ISSN: 0021-924X            Impact factor:   3.387


  7 in total

1.  Regulation of actin dynamics by annexin 2.

Authors:  Matthew J Hayes; Dongmin Shao; Maryse Bailly; Stephen E Moss
Journal:  EMBO J       Date:  2006-04-06       Impact factor: 11.598

Review 2.  Membrane trafficking in osteoblasts and osteoclasts: new avenues for understanding and treating skeletal diseases.

Authors:  Haibo Zhao
Journal:  Traffic       Date:  2012-07-24       Impact factor: 6.215

3.  Annexin 2 binding to phosphatidylinositol 4,5-bisphosphate on endocytic vesicles is regulated by the stress response pathway.

Authors:  Matthew J Hayes; Christien J Merrifield; Dongmin Shao; Jesus Ayala-Sanmartin; Crislyn D'Souza Schorey; Tim P Levine; Jezabel Proust; Julie Curran; Maryse Bailly; Stephen E Moss
Journal:  J Biol Chem       Date:  2004-01-20       Impact factor: 5.157

Review 4.  Immune Function and Diversity of Osteoclasts in Normal and Pathological Conditions.

Authors:  Maria-Bernadette Madel; Lidia Ibáñez; Abdelilah Wakkach; Teun J de Vries; Anna Teti; Florence Apparailly; Claudine Blin-Wakkach
Journal:  Front Immunol       Date:  2019-06-19       Impact factor: 7.561

5.  Annexin A2 heterotetramer: structure and function.

Authors:  Alamelu Bharadwaj; Moamen Bydoun; Ryan Holloway; David Waisman
Journal:  Int J Mol Sci       Date:  2013-03-19       Impact factor: 5.923

6.  A Comparative Study of Cathepsin D Expression in Peripheral and Central Giant Cell Granuloma of the Jaws by Immunohistochemistry Technique.

Authors:  Massoumeh Zargaran; Abbas Moghimbeigi; Noushin Afsharmoghadam; Mohsen Nasr Isfahani; Atefeh Hashemi
Journal:  J Dent (Shiraz)       Date:  2016-06

7.  Biological Evaluation and Transcriptomic Analysis of Corylin as an Inhibitor of Osteoclast Differentiation.

Authors:  Anna Xiao-Dan Yu; Jian Xiao; Shi-Zheng Zhao; Xiang-Peng Kong; Kenneth Kin-Leung Kwan; Brody Zhong-Yu Zheng; Kevin Qi-Yun Wu; Tina Ting-Xia Dong; Karl Wah-Keung Tsim
Journal:  Int J Mol Sci       Date:  2021-03-29       Impact factor: 5.923

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.